Experimental vaccine shows promise in fight against breast cancer

New York: An experimental vaccine is safe and effectively stimulates the immune system leading to regression of early-stage breast cancer, show results of a clinical trial.The researchers created the vaccine from immune cells called dendritic cells that are harvested from each individual patient to create a personalised vaccine.The immune cell vaccine targets the HER2 protein on breast cancer cells. The HER2 protein is overexpressed in 20-25 percent of all breast cancer tumors and is associated